MRSN - Mersana Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
No. of Analysts8887
Avg. Estimate-0.5-0.49-1.95-1.53
Low Estimate-0.56-0.59-2.32-2.43
High Estimate-0.44-0.35-1.35-0.91
Year Ago EPS-0.55-0.61-2.18-1.95
Revenue EstimateCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
No. of Analysts7787
Avg. Estimate8.52M8.84M39.67M76.24M
Low EstimateN/AN/A7.8M15.44M
High Estimate14M14M86M139.65M
Year Ago Sales4.28M5.57M26.58M39.67M
Sales Growth (year/est)98.90%58.60%49.20%92.20%
Earnings History6/29/20229/29/202212/30/20223/30/2023
EPS Est.-0.52-0.09-0.5-0.44
EPS Actual-0.55-0.61-0.44-0.52
Difference-0.03-0.520.06-0.08
Surprise %-5.80%-577.80%12.00%-18.20%
EPS TrendCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
Current Estimate-0.5-0.49-1.95-1.53
7 Days Ago-0.5-0.49-1.95-1.53
30 Days Ago-0.51-0.52-2.03-1.75
60 Days Ago-0.51-0.52-2.03-1.75
90 Days Ago-0.51-0.53-2-1.76
EPS RevisionsCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days4656
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesMRSNIndustrySector(s)S&P 500
Current Qtr.9.10%N/AN/AN/A
Next Qtr.19.70%N/AN/AN/A
Current Year10.60%N/AN/AN/A
Next Year21.50%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A